Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma
- 23 October 2010
- journal article
- Published by Springer Nature in Endocrine
- Vol. 38 (2) , 276-282
Abstract
The expression of X-linked inhibitor of apoptosis (XIAP) and the P2X7 receptor were demonstrated in a variety of tumors. The purpose of the present study was to investigate the associations of XIAP and P2X7 receptor expression with the clinicopathological features of patients with papillary thyroid carcinoma (PTC). In this cross-sectional study, a total of 62 cases were examined, including 43 patients with PTCs and 19 with benign nodular goiters. XIAP and P2X7 receptor expression were examined by immunohistochemical methods on formalin-fixed, paraffin-embedded thyroid tissues. The staining intensity and extent were evaluated and scored using a semi-quantitative method. The immunohistochemical staining score integrating the intensity and extent of XIAP and P2X7 receptors in PTCs was higher than in nodular goiters. XIAP (OR: 5.6, 95% CI: 1.5–21.1, P = 0.009) and P2X7 receptor (OR: 6.1, 95% CI: 1.5–24.4, P = 0.007) expression were associated with lymph node metastasis in PTCs. In logistic regression analysis, P2X7 receptor expression, tumor size, and capsular infiltration were predictors for lymph node metastasis (P = 0.001). Our results suggested that XIAP and P2X7 receptor expression may predict the aggressiveness of PTC.Keywords
This publication has 39 references indexed in Scilit:
- Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cellsCancer Letters, 2010
- P2X7 receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct originPurinergic Signalling, 2009
- The Expression of Monocyte Chemotactic Protein-1 in Papillary Thyroid Carcinoma Is Correlated with Lymph Node Metastasis and Tumor RecurrenceThyroid®, 2009
- Increased P2X7 Receptor Expression and Function in Thyroid Papillary Cancer: A New Potential Marker of the Disease?Endocrinology, 2007
- BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical ImplicationsEndocrine Reviews, 2007
- Risk Factors for Recurrence to the Lymph Node in Papillary Thyroid Carcinoma Patients without Preoperatively Detectable Lateral Node Metastasis: Validity of Prophylactic Modified Radical Neck DissectionWorld Journal of Surgery, 2007
- A2A adenosine receptor protects tumors from antitumor T cellsProceedings of the National Academy of Sciences, 2006
- Pathophysiology and Therapeutic Potential of Purinergic SignalingPharmacological Reviews, 2006
- Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptorJournal of Endocrinological Investigation, 2002
- Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinomaEuropean Journal of Cancer, 2001